Back to UBS Group AG UBS Group AG

CGTXCGTX
16 quarters

Position history for UBS Group AGUBS Group AG's holdings in COGNITION THERAPEUTICS INC

UBS Group AG holds 218,536 shares of CGTX (COGNITION THERAPEUTICS INC), worth $251,316 as of 2026-Q2. The position was increased (+184.3% shares).

Current Value

$251,316

Current Shares

218,536

Total Value Change

+$227,316

Total Shares Change

+214,787

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
218,536
+184.3%
$251,3160.0%$1.15
25
2026-Q1
Increased
76,873
+3.4%
$58,3470.0%$1.02
15
2025-Q4
Increased
74,332
+12.6%
$100,3480.0%$1.37
17
2025-Q3
Increased
66,039
+486.8%
$89,1530.0%$1.43
24
2025-Q2
Increased
11,255
+11.3Kx
$3,4890.0%$0.30
15
2025-Q1
Decreased
1
-100.0%
$00.0%$0.42
0
2024-Q4
Decreased
41,112
-79.2%
$28,8200.0%$0.75
0
2024-Q3
New
197,859
-
$92,7960.0%$0.42
33
2023-Q3
Exited
0
-100.0%
$00.0%$1.44
0
2023-Q2
New
610
-
$1,1160.0%$1.75
17
2023-Q1
Exited
0
-100.0%
$00.0%$1.94
0
2022-Q4
Increased
5,543
+74.0%
$11,6400.0%$2.10
18
2022-Q3
Increased
3,185
+254.3%
$6,0000.0%$1.98
17
2022-Q2
Decreased
899
-76.0%
$2,0000.0%$2.16
0
2022-Q1
Unchanged
3,749
0.0%
$10,0000.0%$2.66
0
2021-Q4
New
3,749
-
$24,0000.0%$6.02
29

Other major holders of CGTX: DAVENPORT & Co LLC, VANGUARD GROUP INC, Pathstone Holdings, LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used